Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Comparison of Drug Prescriptions Before and After Computerized Drug Utilization Review Program Installation in a Tertiary Hospital Setting

3차 의료기관에서 전산화의약품사용평가프로그램 설치 전후의 의약품처방 비교

  • 김상미 (숙명여자대학교 약학대학) ;
  • 손현순 (숙명여자대학교 약학대학) ;
  • 신현택 (숙명여자대학교 약학대학)
  • Received : 2010.12.31
  • Accepted : 2011.03.13
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Drug Utilization Review (DUR) is known to play an important role to improve appropriateness of drug prescriptions. This retrospective, observational study was conducted to compare prescription patterns after installation of Computerized DUR Program (Drug Information Framework-$Korea^{TM}$) (Jan-Mar 2008; After) to before DUR program (Jan-Mar 2007: Before). 8 physicians affiliated in the S University Hospital were enrolled in the study and their 3 months' prescription data were analysed for drug prescription trends and DUR conflict events per 7 DUR screening modules (drugdrug interaction, therapeutic duplication, allergy, dosing, disease contra-indication, geriatric contra-indication, pediatric contra-indication). Average rate of DUR modules usage in 2008 (After) were 0.72. Average number of prescription drug per patient were reduced from 5.6 (Before) to 3.8 (After), and DUR program seemed to effect positively on physician's prescription related decision process. Overall DUR conflict events occurred by 8 physicians for 3 months were 17,923 Before and 20,057 After DUR program, and DUR conflict events per prescription were 2.8 Before and 2.9 After, respectively. Therapeutic duplication (37%), geriatric contra-indication (34%) and dosing (18%) were high ranked DUR conflicts. As the study was not sufficient to show a consistent trend to reduce DUR conflicts After, another study to confirm it's effectiveness would be recommended. This study would be of help to develop awareness of DUR program to healthcare providers.

Keywords

References

  1. National Academy of Sciences Institute of Medicine. To err is human: Building a Safer Health System. Washington, DC: National Academy Press; 1999. Available at http://books.nap.edu/books/0309068371/html/. Accessed August 2009.
  2. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL and Lipton RB. Identification of Serious Drug-Drug Interactions: Results of the Partnership to Prevent Drug-Drug Interactions. J Am Pharm Assoc 2004; 44(2): 142-151. https://doi.org/10.1331/154434504773062591
  3. Lazarou J, Pomeranz BH and Corey PN. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA 1998; 279: 1200-1205. https://doi.org/10.1001/jama.279.15.1200
  4. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC and Hiatt H. The nature of adverse events in hospitalized patients. N Engl J Med 1991; 324: 377-384. https://doi.org/10.1056/NEJM199102073240605
  5. Johnson JA and Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155: 1949-1956. https://doi.org/10.1001/archinte.1995.00430180043006
  6. Ernst FR and Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192-199.
  7. 김민선, 최윤아, 류윤미, 한현주, 이병구, 박경호, 조남춘. 외래환자 처방전상에 나타난 약물 상호작용 실태 및 병원조제담당 약사의 인지도 조사. J Kor Hosp Pharm 1999; 16(2): 252-258.
  8. 신현택. 전산화 DUR프로그램을 통한 국민건강보험 약제비심사 효율성 향상 방안에 대한 연구. 건강보험심사평가원 연구보고서 2003년 6월.
  9. 신현택. 약화사고의 규모파악과 예방대책에 대한 정책연구보고서. 2006. 9. 28.
  10. 배성미. 각 약물의 Drug Use Evaluation에 의한 적정성 추구. J Kor Soc Health-Syst Pharm 2001; 18(4): 433-439.
  11. Alan L, Betsy S, Thomas R. F, Theodore M. C. Ambulatory Drug Utilization Review: Opportunities for Improved Prescription Drug Use. AJMC 2001; 7(1): 75-83.
  12. 의약품사용평가(DUR) 학술정보집. 대한약사회 2004년.
  13. Soumerai SB and Lipton HL. Computer-Based Drug-Utilization Review-Risk, Benefit, or Boondoggle? N Engl J Med 1995; 332: 1641-1645. https://doi.org/10.1056/NEJM199506153322411
  14. 김수미. 히스타민-2 수용체 길항제의 약물사용평가를 통한의약분업 전후의 약제서비스 질 개선 평가 연구. 서울대학교 보건대학교 석사학위논문 2003년 8월.
  15. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel. Drug Utilization Review: Mechanisms to Improve Its Effectiveness and Broaden Its Scope. J Am Pharm Assoc 2000; 40(4): 538-545.
  16. 건강보험심사평가원 .약제정보 -처방조제안전정보 . Available at http://www.hira.or.kr/common/dummy.jsp?pgmid = HIRAF011305000000. Accessed on April, 2010.
  17. Forni A, Chu HT, Fanikos J. Technology utilization to prevent medication errors. Curr Drug Saf. 2010 Jan; 5(1): 13-8. https://doi.org/10.2174/157488610789869193
  18. David H. S, Nancy P, Adrianne F, Xiuhai Y, Daniel K, Steven R. S, Dean F. S, Richard Platt, Soumerai S. B. The Impact of Prescribing Safety Alerts for Elderly Persons in an Electronic Medical Record. Arch Intern Med. 2006; 166: 1098-1104. https://doi.org/10.1001/archinte.166.10.1098
  19. Jean-Pierre G, Jocelyne M, Louise P, Isabelle C, Rene V, Alain M. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study. BMC Health Medical Research. 2006; 6: 1-11.